Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Stock Market Today: Nasdaq leads Wall Street losses as crude oil tops $95; Indian markets likely to open weak – Markets

Traders monitor market movements as Wall Street ends lower on rising oil prices and inflation concerns, while GIFT Nifty signals a weak opening for Indian equity markets. (Image: Canva/ET Now) Stock Market Today: US markets closed lower on Wednesday (local time), with the Nasdaq Composite emerging as the biggest laggard among the benchmark indices as…

Read More
Dr. Reddy's Laboratories shares will react to weak Q1 after US-listed ADR falls 10%

Dr. Reddy’s Laboratories shares will react to weak Q1 after US-listed ADR falls 10%

Shares of Hyderabad-based drugmaker Dr. Reddy’s Laboratories Ltd. will be in focus on Thursday, July 23, after reporting a weaker-than-expected quarterly performance for the June quarter. The company’s American Depository Receipts (ADRs) or those shares listed in the US, fell 10% overnight, in response to the results. Brokerage firm Motilal Oswal has maintained its “neutral”…

Read More
Paytm wants ₹40,000 cr in cash–A stockpile equal to nearly half its market capitalisation

Paytm wants ₹40,000 cr in cash–A stockpile equal to nearly half its market capitalisation

Paytm CEO Vijay Shekhar Sharma aims for a ₹40,000 crore cash balance, nearly half its market cap. This conservative strategy follows regulatory challenges. By Yoosef K   July 22, 2026, 4:44:34 PM IST (Updated) Paytm’s cash pile could eventually approach nearly half of its current market capitalisation, with founder and Chief Executive Officer Vijay Shekhar Sharma…

Read More
Dr Reddy’s ADR falls 5% as profit drops sharply - Check details

Dr Reddy’s Q1 Results: Semaglutide API provision weighs on profit; margin halves

Dr Reddy’s Laboratories reported a weak set of earnings for the June quarter, with profit, revenue and operating performance missing CNBC-TV18 estimates by a wide margin. The pharmaceutical major also posted a sharp year-on-year decline across key financial metrics, underscoring pressure on profitability during the quarter. The company reported a net profit of ₹443.5 crore,…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Nifty, Sensex Prediction Today, 23 July: Indices likely to extend loses amid rising oil and global headwinds; key levels to watch on Thursday – Markets

Sensex, Nifty Prediction Today, July 23: Nifty is expected to test the crucial 23,800 support zone while the Sensex eyes support near 76,100. Nifty, Sensex Prediction Today, 23 July: Benchmark equity indices extended their losing streak to a third straight session on Wednesday, with the Sensex and Nifty tumbling nearly 1 per cent following a…

Read More